The role of proteoglycans in contributing to placental thrombosis and fetal growth restriction
- PMID: 21490795
- PMCID: PMC3065915
- DOI: 10.1155/2011/928381
The role of proteoglycans in contributing to placental thrombosis and fetal growth restriction
Abstract
Fetal growth restriction is an important pregnancy complication that has major consequences for the fetus and neonate as well as an increased risk of long-term morbidity extending into adulthood. The precise aetiology of most cases of fetal growth restriction is unknown although placental thrombosis is a common feature in many of these cases. This paper will outline the potential role of proteoglycans in contributing to placental thrombosis and fetal growth restriction.
References
-
- Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS. Fetal nutrition and cardiovascular disease in adult life. The Lancet. 1993;341(8850):938–941. - PubMed
-
- Maulik D. Fetal growth restriction: the etiology. Clinical Obstetrics and Gynecology. 2006;49(2):228–235. - PubMed
-
- Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clinical Obstetrics and Gynecology. 2006;49(2):219–227. - PubMed
-
- Sugimura M, Ohashi R, Kobayashi T, Kanayama N. Intraplacental coagulation in intrauterine growth restriction: cause or result? Seminars in Thrombosis and Hemostasis. 2001;27(2):107–114. - PubMed
-
- Gerbasi FR, Bottoms S, Farag A, Mammen E. Increased intravascular coagulation associated with pregnancy. Obstetrics and Gynecology. 1990;75(3 I):385–389. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
